NasdaqCM - Nasdaq Real Time Price USD
Cibus, Inc. (CBUS)
3.0900
+0.2400
+(8.42%)
At close: May 28 at 4:00:01 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-56,390
-58,043
-46,210
-19,364
-18,811
Investing Cash Flow
-871
-808
55,060
-1,520
11,201
Financing Cash Flow
56,348
40,598
20,320
9,989
3,742
End Cash Position
23,594
14,433
32,699
3,526
14,421
Interest Paid Supplemental Data
--
--
123
69
1,425
Capital Expenditure
-871
-808
-4,321
-1,520
-497
Issuance of Capital Stock
59,967
43,902
20,306
11,538
4,380
Issuance of Debt
--
204
3,878
0
0
Repayment of Debt
-797
-1,083
-1,572
-376
-364
Free Cash Flow
-57,261
-58,851
-50,531
-20,884
-19,308
12/31/2021 - 7/20/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ONTTF Oxford Nanopore Technologies plc
1.7300
+10.90%
IKT Inhibikase Therapeutics, Inc.
2.0400
+15.25%
MLTX MoonLake Immunotherapeutics
38.17
-1.06%
PVLA Palvella Therapeutics, Inc.
23.83
+3.88%
4598.T Delta-Fly Pharma, Inc.
603.00
0.00%
BT1.BE Bone Therapeutics SA
0.0017
-5.56%
WQ5.F Genflow Biosciences plc
0.0100
0.00%
TNGX Tango Therapeutics, Inc.
1.9400
-5.37%
AURX Nuo Therapeutics, Inc.
1.5490
0.00%
BCYC Bicycle Therapeutics plc
8.20
+2.12%